These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15616276)

  • 1. Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.
    Monk BC; Niimi K; Lin S; Knight A; Kardos TB; Cannon RD; Parshot R; King A; Lun D; Harding DR
    Antimicrob Agents Chemother; 2005 Jan; 49(1):57-70. PubMed ID: 15616276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
    Niimi K; Harding DR; Parshot R; King A; Lun DJ; Decottignies A; Niimi M; Lin S; Cannon RD; Goffeau A; Monk BC
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1256-71. PubMed ID: 15047528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
    Billack B; Santoro M; Lau-Cam C
    Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of the growth and plasma membrane H
    Orie NN; Warren AR; Basaric J; Lau-Cam C; Piętka-Ottlik M; Młochowski J; Billack B
    J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28151580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
    Lamping E; Ranchod A; Nakamura K; Tyndall JD; Niimi K; Holmes AR; Niimi M; Cannon RD
    Antimicrob Agents Chemother; 2009 Feb; 53(2):354-69. PubMed ID: 19015352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
    Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
    PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296.
    Ben-Josef AM; Manavathu EK; Platt D; Sobel JD
    Int J Antimicrob Agents; 2000 Feb; 13(4):287-95. PubMed ID: 10755243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor.
    Niimi K; Harding DR; Holmes AR; Lamping E; Niimi M; Tyndall JD; Cannon RD; Monk BC
    Mol Microbiol; 2012 Aug; 85(4):747-67. PubMed ID: 22788839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
    Basso LR; Gast CE; Bruzual I; Wong B
    J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
    Wu Y; Gao N; Li C; Gao J; Ying C
    FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel antifungal nonapeptide generated by combinatorial approach.
    Kumar M; Chaturvedi AK; Kavishwar A; Shukla PK; Kesarwani AP; Kundu B
    Int J Antimicrob Agents; 2005 Apr; 25(4):313-20. PubMed ID: 15784311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.